Clinical trials
Lipids clinical trials
Below are recruiting lipids clinical trials, each written for real people, not researchers. We’re tracking 167 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06193668Recruiting
Overfeeding and fat tissue stimulation study
This trial looks at how overfeeding affects fat tissue in healthy, inactive young adults. You may help researchers understand weight gain and metabolism.
Düsseldorf, North Rhine-WestphaliaAges 18–40 - NCT04031508Enrolling by invitationPhase 2
Omega-3 in an IV for newborns with breathing circulation problems
This trial tests whether giving an omega-3 fat medicine through an IV (along with standard care) improves breathing and blood-flow problems in newborns with congenital diaphragmatic hernia and persistent pulmonary hypertension. It may help reduce strain on the lungs and heart by targeting inflammation and blood-vessel changes.
Mexico City, Mexico CityAges 1 hour–2 weeks - NCT04523701RecruitingPhase 3
Testing a “white test” to find bile ducts during liver surgery
This trial studies whether a simple “white test” using a special lipid (fat-like) solution can help the surgical team spot open bile ducts early during liver removal. Finding them sooner may help prevent bile leakage after liver surgery.
AarauAges 18 years+ - NCT06802978Recruiting
Lipid test in diabetic and non-diabetic kidney patients
This study checks cholesterol and fat levels in the blood of people with chronic kidney disease, comparing those with and without diabetes. It aims to understand how kidney disease affects lipid profiles.
SohagAges 21 years+ - NCT06066775Recruiting
Glucose, fats, and brain health in aging
This study looks at how blood sugar and fat levels relate to brain aging over time. It may help understand why some people's brains age faster than others.
Jinan, ShandongAges 50 years+ - NCT07534241Recruiting
Reishi Mushroom for Fatty Liver Disease
This study tests whether reishi mushroom (a type of fungus) can improve liver health in people with metabolic dysfunction-associated fatty liver disease—a condition where fat builds up in the liver. Researchers want to see if this natural supplement can reduce liver inflammation and improve blood sugar and cholesterol levels.
LahoreAges 35–65 - NCT07082348Recruiting
Herbs and spices for better diet in college students
This study tests whether adding herbs and spices to your daily meals can help improve your diet quality over a short period. It is designed for college students who feel their eating habits could be healthier.
Las Vegas, NevadaAges 18–39 - NCT06090890RecruitingPhase 4
Anti-inflammatory therapy for repeated stent blockages
This trial tests if anti-inflammatory drugs like prednisone or colchicine can prevent stents from blocking again in people who have already had multiple stent blockages. It may offer a new treatment option for those with recurrent in-stent restenosis.
Beijing, Beijing MunicipalityAges 18 years+ - NCT07352618Enrolling by invitation
Omega-3 supplements for blood sugar and cholesterol in type 2 diabetes
This study tests whether adding omega-3 supplements to your regular diabetes treatment can improve blood sugar control and cholesterol. It may help people with type 2 diabetes who are already on medication.
DhakaAges 25–75 - NCT06994871Enrolling by invitation
Exercise and liver fat in fatty liver disease
This study tests if different types of exercise can reduce fat in the liver for people with metabolic fatty liver disease. It might help if you are looking for a non-drug way to improve your liver health.
Nanjing, JiangsuAges 18–45 - NCT06861153Recruiting
Study on eating more beans and lentils for heart health
This trial looks at whether eating more beans, lentils, chickpeas, and peas (called pulses) over 12 weeks can improve your heart and metabolic health. It is for people who currently eat less than 1.5 cups of these foods per week and are willing to add more to their diet.
Tucson, ArizonaAges 18–75 - NCT05783804Recruiting
Early cholesterol-lowering to help reverse artery plaque
This trial studies whether starting strong cholesterol-lowering treatment early can reduce or reverse plaque in the arteries. It may help protect the heart over time, especially for people with inherited high cholesterol.
Amsterdam, North HollandAges 18–50 - NCT06693752RecruitingPhase 2
Ultrasound test for fluid on the brain in babies
This trial uses a special ultrasound with contrast to study fluid on the brain (hydrocephalus) in newborn babies. The aim is to learn more about the condition and improve treatment options.
Philadelphia, PennsylvaniaAges 1 minute–1.5 years - NCT07331103Recruiting
Can a special diet reduce inflammation for heart health?
This study tests whether a special diet can reduce inflammation and improve heart health in people over 55 who are at increased risk for heart disease but have not yet had a heart attack or stroke.
Avellino, AVAges 55 years+ - NCT03866382RecruitingPhase 2
Immunotherapy plus a targeted drug for rare genitourinary tumors
This Phase 2 study tests whether nivolumab and ipilimumab (immunotherapy drugs) plus cabozantinib (a targeted anti-cancer drug) can shrink or control rare cancers of the urinary/reproductive system that have spread. It may help by boosting the immune system and blocking cancer growth signals at the same time.
Birmingham, AlabamaAges 18 years+ - NCT07743073Recruiting
Ceylon cinnamon for diabetic nerve pain
This study tests whether taking Ceylon cinnamon daily can help lower blood sugar, improve cholesterol, and reduce nerve pain in adults with type 2 diabetes and painful diabetic peripheral neuropathy. If you qualify, you might get a natural supplement that could ease your symptoms.
AmmanAges 18 years+ - NCT06067399Recruiting
Red blood cell width and blood sugar in type 2 diabetes
This study looks at two blood test results—HbA1c (average blood sugar) and red blood cell width (RDW)—in people with type 2 diabetes whose blood sugar is not well controlled. The goal is to see how these two measurements relate after improving blood sugar management.
Al KhārjahAges 40 years+ - NCT07727265Recruiting
Sepsis and blood vessel injury study
This trial is testing a new approach to understand how sepsis (a severe infection) damages blood vessels. It looks at tiny particles released by cells and a protein called PLIN3 to see if they can help protect blood vessels in patients with sepsis.
Nanjing, JiangsuAges 18–80 - NCT07491172RecruitingPhase 1
Trial of CTX310 for stubborn high cholesterol and fats
This trial tests a new medicine, CTX310, for people with persistently high levels of fats (triglycerides) and cholesterol that have not improved with standard treatments. It aims to see if the drug is safe and tolerable.
Hialeah, FloridaAges 18–75 - NCT07720232RecruitingPhase 4
Probiotic plus lipid-lowering for pancreatitis from high triglycerides
This trial tests if adding a probiotic (Bacillus subtilis and Enterococcus faecium) to standard lipid-lowering therapy helps people with mild pancreatitis caused by very high triglycerides. It aims to see if the combination reduces inflammation and speeds recovery.
Xiamen, FujianAges 18–65 - NCT06049680RecruitingPhase 4
Safety study of SMOFlipid for patients needing IV nutrition
This trial tests if SMOFlipid, a special lipid emulsion given through an IV, is safe for children and adults who need most of their nutrition from IV for at least 8 weeks. It looks for side effects like essential fatty acid deficiency or liver problems.
Atlanta, GeorgiaAges 1 month–17 years - NCT03490929RecruitingPhase 4
Ultrasound contrast test for abdominal injuries in children
This trial checks whether a special ultrasound (with contrast) can help doctors evaluate blunt abdominal injuries in children. It may reduce the need for rushed decisions by improving how internal injuries are seen quickly and safely.
Rochester, MinnesotaAges birth–17 years - NCT03669809Recruiting
Study of how body timing affects metabolism
This trial looks at how “biological rhythm” (your body’s timing over the day and night) relates to metabolism, or how your body processes energy. It may help researchers understand whether timing patterns affect health and metabolic functions.
Jinan, ShandongAges 18–30 - NCT03818178Recruiting
Study of gut-delivered fats and insulin resistance
This study looks at how sending certain fats through the intestine affects “insulin resistance,” a condition where the body doesn’t use insulin as well. If you qualify, you may receive a controlled lipid (fat) delivery as part of measuring body fat handling and related body chemistry.
Rochester, MinnesotaAges 18–55
Hear when a new Lipids trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for lipids?
- Yes. Clin2 currently lists 167 recruiting lipids studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a lipids trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a lipids trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.